Johnson & Johnson MedTech on Monday said it named Kurt Van den Bosch as chief financial officer, group finance.
Van den Bosch will be a member of Johnson & Johnson’s global finance team, reporting to company Executive Vice President and CFO Joe Wolk. Van den Bosch’s role includes providing financial leadership to the global Johnson & Johnson MedTech organization.
He most recently served as area vice president of midsized markets for J&J MedTech EMEA, overseeing the Europe, Middle East & Africa business that included the markets of Austria, Belgium, Greece, Israel, Portugal, Switzerland, the Netherlands and Scandinavian countries.
Van den Bosch joined Johnson & Johnson’s Janssen Pharmaceuticals, Belgium, company in 1990 as part of its finance team and has held a range of roles with increasing responsibility since. Before joining J&J MedTech, he was CFO for Janssen EMEA from 2012 to 2014, before being appointed to the role of CFO for global surgery EMEA in 2014, then CFO for medical devices EMEA in 2015.